Media Releases

IVF Advance - 70 babies born from embryos that would have previously been discarded

Posted: 26/07/2023 1:40:53 PM
 A study by Genea Fertility scientists has led to the birth of 70 healthy babies from the use of embryos which would have previously been deemed unfit for use and discarded.

Embryos created during fertility treatment are graded on their appearance during the early stages of development. Traditionally embryos classified as 1PN (one pro-nuclei) were believed to have insufficient genetic material to be viable and were therefore discarded.

However, Genea Fertility embryologists believed a number of 1PN embryos had the potential to achieve successful pregnancies, despite the lack of genetic material seen during early development.

Genea becomes Platinum Sponsor for Australian Jewish Fertility Network Event

Posted: 10/08/2022 12:00:00 PM
On 10 August 2022, Genea Fertility was a platinum sponsor of the Australian Jewish Fertility Network’s (AJFN) annual major fundraising event. The night had everything including a raffle, live original music performances, immersive media and candid, emotional stories. All proceeds from the event go towards helping the 44 families in the Jewish community who need help to try to create their miracle baby.

The Fertility Tales; breaking down the barriers around fertility

Posted: 23/05/2022 1:48:19 PM
Even in 2022, fertility is often a taboo topic that many shy away from. At Genea, we want to break these barriers, open up the conversation and reshape how people think and talk about fertility and infertility.
That’s why we launched The Fertility Tales, the first magazine of its kind in Australia.  It’s a fertility specific magazine produced by AllBright and sponsored by Genea, to facilitate discussion around fertility, genetic testing and more.

The Fertility Tales contains many moving stories about women who have struggled to conceive, advice on how to mentally and physically prepare for IVF, the importance of genetic testing, surrogacy, adoption, the loss of miscarriage and more.

You can order your own copy here, for free.

Pregnant women undergoing unnecessary invasive procedures

Posted: 31/01/2022 9:27:38 AM
GeneSyte is a non-invasive genetic prenatal screening test which can be done as early as 10 weeks or at any time throughout pregnancy.  It takes a sample of the mothers blood which contains the baby’s DNA and can accurately detect chromosomal changes in the baby during pregnancy.
A recent study of 1,000 pregnant women demonstrated the accuracy of GeneSyte  by identify that 42 women would have been incorrectly classified as high risk and referred for CVS (Chorionic Villus Sampling) or Amniocentesis where only 5 pregnant women actually needed such invasive diagnostic testing.

GeneSyte is a simple blood test that can offer you piece of mind. Download a referal form

Aussie scientists develop breakthrough in IVF treatment

Posted: 11/06/2021 10:00:00 AM
Pioneered by Australian scientists, Genea’s Geri® incubator combined with an updated version of the fluid embryos develop in, has resulted in a staggering 12.2% increase in the number of live births for those struggling to conceive*. The cutting-edge technology is the closest yet to emulating what occurs in the mother’s womb, allowing embryos to grow undisturbed, mirroring the journey in the mother’s fallopian tubes prior to implantation.

Hope for families as Government delivers

Posted: 11/05/2021 12:56:13 PM
After more than a decade of lobbying the Government to provide funding for preimplantation genetic diagnosis (PGD) the Morrison Government has announced $95.9 million will be allocated to new tests on the MBS for genetic testing of embryos for specific chromosomal abnormalities.

Genea Biomedx and Hamilton Thorne partner to grow Genea Biomedx operations and support customers in USA and Canada

Posted: 13/11/2020 12:00:00 AM
Australian fertility innovator Genea Biomedx has entered into a collaboration agreement with Hamilton Thorne Ltd, a leading provider of products and services to the Assisted Reproductive Technologies markets.

Position Statement

Posted: 10/10/2020 12:44:44 PM
Genea's Scientific Director Steven McArthur on non-invasive Pre-implantation Genetic Screening.

Baby Steps: Pandemic turns GPs to podcasting for fertility information

Posted: 15/07/2020 2:22:21 PM
In an industry first, Genea Fertility, The Misfits Media and Ward 6 have combined to launch a podcast designed specifically for health care practitioners. The Baby Steps by Genea series provides clinicians with much needed advice on how to support patients struggling with infertility, both during the COVID-19 pandemic and beyond.

COVID-19: Victorian patients

Posted: 15/07/2020 11:20:26 AM
Following advice from the Department of Health and Human Services, all Victorian patients living or working within a Stage 3 restriction zone or other known hotspot will need to be tested for COVID-19 before being admitted to hospital, including for fertility treatment.
First  Previous  1  2  Next  Last

Media Contact

Alexandra Suvajac
Media Enquiries
M: 0436 489 199


Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with over 35 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. 

More on Genea in the news